Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says

The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's (LLY.N) diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand.